Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

This study found that approximately 1 in 1000 UKB participants were LP/P TTR variant carriers, exceeding previously reported prevalence. The findings emphasize the need for clinical vigilance in identifying individuals at risk of developing vATTR and associated poor outcomes.